KLK1 and systemic lupus erythematosus: Using the MRL/lpr mice, a popularly used lupus-prone model, we show in a short-term study that exogenous Klk1 administration reduced depressive-like behavior, key interferon responsive genes (IRGs), and proinflammatory responses.